ARCH Venture Partners IX, LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ARCH Venture Partners IX, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ARCH Venture Partners IX, LLC. ARCH Venture Partners IX, LLC is 10% Owner in Gossamer Bio, Inc. ($GOSS) and 10% Owner in Vir Biotechnology, Inc. ($VIR) and 10% Owner in Beam Therapeutics Inc. ($BEAM) and 10% Owner in Karuna Therapeutics, Inc. ($KRTX).
Latest Insider Trading Transactions of ARCH Venture Partners IX, LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BEAM, GOSS, KRTX, VIR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 2021 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 306 | 0 | 918 | 612 to 918 (+50.00 %) |
| Apr 15 2021 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 958 | 0 | 2,874 | 1.9 K to 2.9 K (+50.00 %) |
| Apr 15 2021 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 75,000 | 0 | 1,456,435 | 1.5 M to 1.5 M (-4.90 %) |
| Apr 15 2021 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 75,000 | 0 | 1,456,437 | 1.5 M to 1.5 M (-4.90 %) |
| Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 1,019 | 0 | 4,068 | 3 K to 4.1 K (+33.42 %) |
| Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 3,161 | 0 | 12,642 | 9.5 K to 12.6 K (+33.34 %) |
| Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 282,219 | 0 | 15,051,678 | 15.3 M to 15.1 M (-1.84 %) |
| Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 217,781 | 0 | 11,614,985 | 11.8 M to 11.6 M (-1.84 %) |
| Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 1,019 | 0 | 3,049 | 2 K to 3 K (+50.20 %) |
| Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 3,161 | 0 | 9,481 | 6.3 K to 9.5 K (+50.02 %) |
| Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 282,219 | 0 | 15,333,897 | 15.6 M to 15.3 M (-1.81 %) |
| Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 217,781 | 0 | 11,832,766 | 12.1 M to 11.8 M (-1.81 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 811 | 0 | 2,434 | 1.6 K to 2.4 K (+49.97 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 2,555 | 0 | 7,663 | 5.1 K to 7.7 K (+50.02 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 200,000 | 0 | 3,521,519 | 3.7 M to 3.5 M (-5.37 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 200,000 | 0 | 3,521,520 | 3.7 M to 3.5 M (-5.37 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 1,016 | 0 | 2,030 | 1 K to 2 K (+100.20 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 3,160 | 0 | 6,320 | 3.2 K to 6.3 K (+100.00 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 282,219 | 0 | 15,616,116 | 15.9 M to 15.6 M (-1.78 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 217,781 | 0 | 12,050,547 | 12.3 M to 12.1 M (-1.78 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 1,014 | 0 | 1,014 | 0 to 1 K |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 3,160 | 0 | 3,160 | 0 to 3.2 K |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 282,219 | 0 | 15,898,335 | 16.2 M to 15.9 M (-1.74 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 217,781 | 0 | 12,268,328 | 12.5 M to 12.3 M (-1.74 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 813 | 0 | 1,623 | 810 to 1.6 K (+100.37 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 2,555 | 0 | 5,108 | 2.6 K to 5.1 K (+100.08 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 200,000 | 0 | 3,721,519 | 3.9 M to 3.7 M (-5.10 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 200,000 | 0 | 3,721,520 | 3.9 M to 3.7 M (-5.10 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 810 | 0 | 810 | 0 to 810 |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 2,553 | 0 | 2,553 | 0 to 2.6 K |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 200,000 | 0 | 3,921,519 | 4.1 M to 3.9 M (-4.85 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 200,000 | 0 | 3,921,520 | 4.1 M to 3.9 M (-4.85 %) |
| Jan 12 2021 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 306 | 0 | 612 | 306 to 612 (+100.00 %) |
| Jan 12 2021 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 958 | 0 | 1,916 | 958 to 1.9 K (+100.00 %) |
| Jan 12 2021 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 75,000 | 0 | 1,531,435 | 1.6 M to 1.5 M (-4.67 %) |
| Jan 12 2021 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 75,000 | 0 | 1,531,437 | 1.6 M to 1.5 M (-4.67 %) |
| Jan 12 2021 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 306 | 0 | 612 | 306 to 612 (+100.00 %) |
| Jan 12 2021 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 958 | 0 | 1,916 | 958 to 1.9 K (+100.00 %) |
| Jan 12 2021 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 75,000 | 0 | 1,531,435 | 1.6 M to 1.5 M (-4.67 %) |
| Jan 12 2021 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 75,000 | 0 | 1,531,437 | 1.6 M to 1.5 M (-4.67 %) |
| Nov 16 2020 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 306 | 0 | 306 | 0 to 306 |
| Nov 16 2020 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 958 | 0 | 958 | 0 to 958 |
| Nov 16 2020 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 75,000 | 0 | 1,606,435 | 1.7 M to 1.6 M (-4.46 %) |
| Nov 16 2020 | KRTX | Karuna Therapeutic ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 75,000 | 0 | 1,606,437 | 1.7 M to 1.6 M (-4.46 %) |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 33,184 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 33,184 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,750,335 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,750,336 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,338,000 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,338,000 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 4,121,519 | 0 | 4,121,519 | 0 to 4.1 M |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 4,121,520 | 0 | 4,121,520 | 0 to 4.1 M |
| Oct 18 2019 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,222,222 | 0 | 0 | |
| Oct 18 2019 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,222,222 | 0 | 0 | |
| Oct 18 2019 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 555,555 | 0 | 0 | |
| Oct 18 2019 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 555,555 | 0 | 0 | |
| Oct 18 2019 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 13,333,332 | 0 | 0 | |
| Oct 18 2019 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 13,333,332 | 0 | 0 | |
| Oct 18 2019 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 11,111,110 | 0 | 0 | |
| Oct 18 2019 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 11,111,110 | 0 | 0 | |
| Oct 18 2019 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | P | 20.00 | 1,000,000 | 20,000,000 | 1,000,000 | 0 to 1000 K |
| Oct 18 2019 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | P | 20.00 | 1,000,000 | 20,000,000 | 1,000,000 | 0 to 1000 K |
| Oct 18 2019 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 15,555,554 | 0 | 15,555,554 | 0 to 15.6 M |
| Oct 18 2019 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 15,555,554 | 0 | 15,555,554 | 0 to 15.6 M |
| Oct 18 2019 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 11,666,665 | 0 | 12,111,109 | 444.4 K to 12.1 M (+2,625.00 %) |
| Oct 18 2019 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 11,666,665 | 0 | 12,111,109 | 444.4 K to 12.1 M (+2,625.00 %) |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,554,388 | 0 | 0 | |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,554,388 | 0 | 0 | |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 16,571,428 | 0 | 0 | |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 16,571,429 | 0 | 0 | |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 345,419 | 0 | 4,027,958 | 3.7 M to 4 M (+9.38 %) |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 3,682,539 | 0 | 3,682,539 | 0 to 3.7 M |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 345,419 | 0 | 4,027,958 | 3.7 M to 4 M (+9.38 %) |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 3,682,539 | 0 | 3,682,539 | 0 to 3.7 M |
Page: 1